Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
about
IL-15 and IL-17F are differentially regulated and expressed in mycosis fungoides (MF).Staphylococcal enterotoxins stimulate lymphoma-associated immune dysregulation.Distinct age-matched serum biomarker profiles in patients with cutaneous T-cell lymphoma.Interleukin (IL)-17A, F and AF in inflammation: a study in collagen-induced arthritis and rheumatoid arthritis.Ectopic expression of embryonic stem cell and other developmental genes in cutaneous T-cell lymphomaThe Use of Transcriptional Profiling to Improve Personalized Diagnosis and Management of Cutaneous T-cell Lymphoma (CTCL).Aberrant Circulating Th17 Cells in Patients with B-Cell Non-Hodgkin's LymphomaEctopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma.Analysis of STAT4 expression in cutaneous T-cell lymphoma (CTCL) patients and patient-derived cell linesStaphylococcal enterotoxin A (SEA) stimulates STAT3 activation and IL-17 expression in cutaneous T-cell lymphomaEctopic expression of cancer-testis antigens in cutaneous T-cell lymphoma patients.Bacterial toxins fuel disease progression in cutaneous T-cell lymphoma.Malignant inflammation in cutaneous T-cell lymphoma-a hostile takeoverInvestigating potential exogenous tumor initiating and promoting factors for Cutaneous T-Cell Lymphomas (CTCL), a rare skin malignancymiRNA in mycosis fungoides and skin inflammation.NFκB function and regulation in cutaneous T-cell lymphoma.Targeted therapies for cutaneous T-cell lymphomas.Cutaneous T cell lymphoma expresses immunosuppressive CD80 (B7-1) cell surface protein in a STAT5-dependent manner.Mechanism, Consequences, and Therapeutic Targeting of Abnormal IL15 Signaling in Cutaneous T-cell Lymphoma.Evaluation of quantum dot cytotoxicity: interpretation of nanoparticle concentrations versus intracellular nanoparticle numbers.Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphomaSTAT5 induces miR-21 expression in cutaneous T cell lymphoma.Th17 cytokine differentiation and loss of plasticity after SOCS1 inactivation in a cutaneous T-cell lymphoma.Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Malignant T cells activate endothelial cells via IL-17 F.Bcl3 regulates pro-survival and pro-inflammatory gene expression in cutaneous T-cell lymphoma.Expression of miR-155 and miR-126 in situ in cutaneous T-cell lymphoma.Role of dysregulated cytokine signaling and bacterial triggers in the pathogenesis of Cutaneous T Cell Lymphoma.
P2860
Q33728396-96C2BACD-0AF2-43E0-B026-3B307B5031C7Q33987080-14D122C6-F027-4309-AC38-B45AB42717FFQ34017170-6FFBE194-E8E9-4289-8BC5-FF71E4999D61Q34065372-F54EE3A7-AC85-419D-93D4-30F051EEECA2Q35201911-BCD4DCC9-83BB-4CC3-AD45-1DBB55A932DAQ35752062-9148B49A-D9D2-4C0A-B699-6CD694271B3CQ35905076-2378AD71-F6EE-43AE-8310-D6E0198CD892Q35987358-3C547B08-9CB9-483D-A142-0A16A389651FQ36020985-339ECC52-5D23-4D57-89E0-B32D60163BBEQ36187589-87CD8D01-8EF1-4D10-A6F8-22D8124000F4Q36675064-35099922-B4D2-49E6-A611-6D6A2008CC97Q36890779-A4351A52-8FA3-4358-AF96-25CC6B6E6B73Q37139517-531E8604-5F23-417B-80E4-461A2A596674Q37723390-9F87BC99-4FC9-4255-A9E7-E4EDF7FAF24EQ37835711-E012FBFA-2EF7-4352-948E-4493701D7303Q38150868-6B15B9D2-9957-4CBE-A1C8-CC2BC08A0219Q38162229-66947DCF-4F8A-4916-AA8A-CE6D38E5A96FQ38229634-935B395C-6C83-44E2-BF91-10761B0A2EC0Q38714687-B259CAA1-E971-45D8-BBBB-B9BE87E81A1FQ38757938-E10953B0-F6F5-4802-B42B-0CEA39FC8DA1Q38758148-8AEA99DD-D04D-48FC-A3D0-2B1F07B03DD2Q38846167-02141962-9A99-45B4-A4B1-FBE8F9011C81Q39665695-E2726586-C734-4869-83E0-70E3F7351FEBQ40688204-609BBFBF-86D9-4A8E-9BCD-9689013D2A3FQ40754578-7462354F-43FB-4F03-8E16-53B75FC2F263Q41316613-5444E8F8-8D26-4100-99DF-BD745DD929BEQ42004035-7CD99CE9-E0B7-47B7-8DEE-EF2C4EBCEDC6Q44374191-22B3C330-E196-4497-9E0A-F9F21DC91B98Q47613529-0B328455-30A2-4B5E-8526-F3FD482BF66B
P2860
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
@en
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
@nl
type
label
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
@en
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
@nl
prefLabel
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
@en
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma.
@nl
P2093
P2860
P50
P1433
P1476
Elucidating the role of interleukin-17F in cutaneous T-cell lymphoma
@en
P2093
Denis Sasseville
Ivan V Litvinov
Mariusz A Wasik
Niels Odum
Youwen Zhou
P2860
P304
P356
10.1182/BLOOD-2013-01-480889
P407
P50
P577
2013-06-25T00:00:00Z